# Elysium Pharmaceuticals Limited – FDA Inspection, Jan 16, 2023

Source: https://www.keypedia.com/records/fda_inspections/elysium-pharmaceuticals-limited/9ed57172-98d1-404f-9159-be89805611dd
Source feed: FDA_Inspections

> FDA inspection 1195116 of Elysium Pharmaceuticals Limited, January 16, 2023. Classification: Voluntary Action Indicated (VAI). 10 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195116
- Company Name: Elysium Pharmaceuticals Limited
- Inspection Date: 2023-01-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 10

## Related Documents

- FDA Inspection 1061759 - 2018-07-13
- FDA Inspection 1030263 - 2017-09-08
- FDA Inspection 911280 - 2014-12-26

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/alan-p-kurtzberg/36ee316e-6d19-44b2-a131-fc254ada4f41)
- [Issuing Officer](https://www.keypedia.com/people/santos-e-camara/18cea942-f6f9-4dec-9ce9-1c01c39009ce)

Company: https://www.keypedia.com/companies/elysium-pharmaceuticals-limited/6249fc41-1206-431f-87ee-b7b13c89e8f4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
